Elicio Therapeutics (ELTX) Net Margin (2020 - 2022)
Elicio Therapeutics' (ELTX) quarterly Net Margin came in at 1123.43% in Q2 2022, up 711250.0% YoY from N/an in Q2 2021, and down 25.03% on a QoQ basis from 898.54% in Q1 2022.
Elicio Therapeutics (ELTX) Net Margin (2020 - 2022) Analysis & Trends
Elicio Therapeutics (ELTX) has 3 years of Net Margin data on file, last reported at 1123.43% in Q2 2022.
- Quarterly Net Margin rose 711250.0% year-over-year to 1123.43% in Q2 2022, while the trailing twelve-month figure through Mar 2023 was 4864.01% (down 457336.0% YoY) and the FY2022 annual result came in at 2242.98%, down 196389.0% from the prior year.
- Net Margin slipped to 1123.43% in Q2 2022, from 898.54% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 55.19% in Q4 2021 to a low of 8235.93% in Q2 2021.
- A 3-year average of 2793.0% and a median of 2414.4% in 2020 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2021 — Net Margin slumped 582152 bps — and 2022, when it surged 711250 bps.
- Tracing ELTX's Net Margin over 3 years: stood at 2838.78% in 2020, then soared by 102 bps to 55.19% in 2021, then plunged by 2136 bps to 1123.43% in 2022.
- The last three Net Margin figures came in at 1123.43% (Q2 2022), 898.54% (Q1 2022), and 55.19% (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 12.74% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -3.12% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -16.51% |
| 10 | Elicio Therapeutics | 59.08 Mn | 35.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1,123.43% |
| Mar 31, 2022 | -898.54% |
| Dec 31, 2021 | 55.19% |
| Sep 30, 2021 | -2,810.68% |
| Jun 30, 2021 | -8,235.93% |
| Mar 31, 2021 | -5,446.36% |
| Dec 31, 2020 | -2,838.78% |
| Sep 30, 2020 | -1,424.06% |
| Jun 30, 2020 | -2,414.40% |